Emerging Phase Cases

Select one of the briefcases from the Emerging Phase Cases below to begin.

Home

Emerging Phase

Emerging

Litigation Phase

Litigation

Settlement Phase

Settlement

ACTEMRA (tocilizumab) by Genentech USA, Inc. (Roche Group)

ABSORB GT1 BIORESORBABLE VASCULAR SCAFFOLD (BVS) by Abbott Vascular

BREAST IMPLANTS

EXACTECH Litigation (Optetrak Knee Replacement Devices)

HEARTSTART MRX ALS MONITOR (HeartStart MRx ALS Monitor) by Philips Healthcare

IMODIUM (loperamide) by Johnson & Johnson Consumer, Inc.

KAYEXALATE (sodium polystyrene sulfonate) by Concordia Pharmaceuticals

KEYTRUDA (pembrolizumab) by Merck Sharp & Dohme Corp.

LAMICTAL (lamotrigine) by GLAXOSMITHKLINE

LEMTRADA (alemtuzumab) by Genzyme Corporation

LIMBREL (flavocoxid) by Primus Pharmaceuticals, Inc.

NUPLAZID (pimavanserin) by ACADIA Pharmaceuticals, Inc.

SMITH & NEPHEW Journey BCS Knee System

TASIGNA (nilotinib hydrochloride monohydrate) by Novartis AG/Novartis Pharmaceuticals, Inc.

ULORIC (febuxostat) by Takeda Pharmaceuticals U.S.A., Inc.

VIBERZI (eluxadoline) by Allergan

Zantac MDL 2924 (Ranatidine) Products Liability Litigation - FL

ZINBRYTA (daclizumab) by Biogen